Think
Forward

Events
Brinks Webinar | Patent Reform: What Should You Be Doing Now? Part II
August 28, 2012
12:00 p.m. - 1:00 p.m. (CDT)

With passage of the America Invents Act (AIA), many changes affecting patent applications and protection of patent rights have been or will soon be implemented. Some key provisions will go into effect on September 16, providing new opportunities to challenge pending applications and issued patents. Final rules are still being published.

Brinks Gilson & Lione attorneys Allen R. Baum and Ryan L. Marshall will discuss the current state of the law, the upcoming changes and strategies for taking advantage of the new proceedings and provisions in the U.S. patent system. The discussion will address aspects of the AIA going into effect on September 16, including:

  • Pre-Issuance Submissions 35 U.S.C. 122(e) and 301
  • Inter Partes Reexam
  • Post Grant Review
  • Inter Partes Review
  • Supplemental Examination


Please join us for the second in a series of timely discussions on what your business should be doing now! View the first installment.

Agenda (all times CST):

12:00 p.m. - 12:05 p.m. Welcome
12:05 p.m. - 12:50 p.m. Panel Discussion
12:50 p.m. - 1:00 p.m. Q & A Session

Brinks is an accredited MCLE provider in Illinois and this program is worth 1.0 hour of general CLE credit. CLE credit in other states may be available on request.

Allen Baum has 20 years of experience as a patent attorney and is frequently retained to develop strategies to bring lucrative products to market in areas heavily patented by competitors. He has evaluated the strength of patents protecting products with sales in excess of $1 billion under consideration for challenge, licensing, acquisition, or investment. He is also a former president of the Licensing Executives Society, USA & Canada.

Ryan Marshall has extensive experience with patent and trademark matters as well as litigation experience with patent, trade secret, trade dress and unfair trade practice claims. He focuses his practice in the chemical, pharmaceutical and biochemical arts.

RELATED PRACTICE GROUPS